-
41
-
42
Gene Therapy for Primary Immunodeficiency
Published 2021-01-01“…Here, we review the key developments in the gene therapy landscape for primary immune deficiency, from an experimental therapy where clinical efficacy was marred by adverse events, to a commercialized product with enhanced safety and efficacy. …”
Get full text
Article -
43
Gene therapy in neuromuscular disorders
Published 2022-08-01“…Abstract Monogenic neuromuscular disorders are potentially treatable through gene therapy. Using viral vectors, a therapeutic transgene aims to restore normal levels of a protein not produced by the defective gene, or to silence a gene whose expression leads to toxic effects. …”
Get full text
Article -
44
Gene Therapy in Pediatric Orthopedics
Published 2024-03-01Subjects: “…gene therapy…”
Get full text
Article -
45
Gene Therapy Today and Tomorrow
Published 2019-04-01“…In the wake of a breakthrough in biotechnology providing realistic application of recombinant expressed proteins as drugs in the 1990s, gene therapy emerged as the potential approach for providing medicines of the future [...]…”
Get full text
Article -
46
-
47
Gene Therapy for Glioblastoma Multiforme
Published 2025-01-01“…The possible benefits of combining gene therapy with standard GBM treatments will also be covered.…”
Get full text
Article -
48
-
49
Viral Vectors in Gene Therapy
Published 2018-05-01“…Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. Significant improvements in vector engineering, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. …”
Get full text
Article -
50
Switching on the lights for gene therapy.
Published 2007-01-01“…Non-invasive assessment of the dynamics of gene regulation is of interest for the detection of endogenous disease-specific biological alterations (e.g., signal transduction) and for monitoring the induction and regulation of therapeutic genes (e.g., gene therapy). To demonstrate that non-invasive imaging of regulated expression of any type of gene after in vivo transduction by versatile vectors is feasible, we generated regulatable herpes simplex virus type 1 (HSV-1) amplicon vectors carrying hormone (mifepristone) or antibiotic (tetracycline) regulated promoters driving the proportional co-expression of two marker genes. …”
Get full text
Article -
51
-
52
Gene therapy for retinitis pigmentosa
Published 2021-01-01Subjects: “…gene therapy…”
Get full text
Article -
53
-
54
Gene therapy for retinal diseases
Published 2014-01-01“…Gene therapy has tremendous potential for different ocular diseases. …”
Get full text
Article -
55
-
56
-
57
The once and future gene therapy
Published 2020-11-01“…Gene therapy is at an inflection point. Recent successes in genetic medicine have paved the path for a broader second wave of therapies and laid the foundation for next-generation technologies. …”
Get full text
Article -
58
GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES
Published 2009-11-01“…This review discusses gene therapy strategies for the hemoglobinopathies, including the use of lentiviral vectors, generation of induced pluripotent stem cells (iPS) cells, gene targeting, splice-switching and stop codon readthrough.…”
Get full text
Article -
59
Gene therapy for colorectal cancer.
Published 2003“…Although the preclinical results of gene therapy for colorectal cancer have shown promise, gene therapy is still at an early stage of clinical development and has not yet shown a significant therapeutic benefit for patients. …”
Journal article -
60